Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045, India
[276 Pages Report] The global weight loss and obesity management market will account for a net worth of US$ 3.68 Billion in 2022, and is predicted to rise at a CAGR of 5.2% over the forecast period to attain a valuation of US$ 4.99 Billion by 2028.
Attributes | Details |
---|---|
Weight Loss and Obesity Management Market Size (2022) | US$ 3.68 Billion |
Sales Forecast (2028) | US$ 4.99 Billion |
Global Market Growth Rate (2022 to 2028) | 5.2% CAGR |
Share of Top 5 Market Players | 50% |
Weight loss and obesity management accounted for 40.9% share of the global obesity treatment market revenue in 2021.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Particulars | Details |
---|---|
H1, 2021 | 5.17% |
H1, 2022 Projected | 5.18% |
H1, 2022 Outlook | 4.78% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 40 ↓ |
BPS Change - H1, 2022 (O) - H1, 2021 | (-) 39 ↓ |
H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 40 BPS. In H1-2022 when compared with H1-2021, the market growth rate of weight loss and obesity management is expected to fall by 39 basis point share (BPS), as per FMI analysis.
The decline in the BPS values is associated with several product and device recalls due to the adverse effects associated with their use. Moreover, limitations in drug therapies for obesity and weight loss such as frequent obesity relapse, has further contributed to the decline in the BPS values.
However, recent approvals from the FDA for semaglutide injections for weight loss and obesity management will propose a positive outlook towards market growth during the forecasted years.
The market is subject to device regulations, product recalls, licencing requirements, and patient safety guidelines, as per the industry and macroeconomic factors. Key developments in the market include the incorporation of endoluminal techniques to treat obesity. This method is as effective as surgical interventions for the management of weight loss and obesity.
“Increasing Prevalence of Obesity & Associated Lifestyle Diseases Driving Market Growth”
From 2013 to 2021, the global weight loss and obesity management market experienced a CAGR of around 4.8%.
The weight loss and obesity management products market covers various product forms such as devices and drugs that are used for managing or reducing weight in obese and overweight patients. Rising global burden of obesity and overweight is driving the need for preventive care.
Obese people are more likely to develop chronic conditions like diabetes, hypertension, and orthopedic problems. As a result, increased awareness of weight-loss procedures is propelling the market forward. Moreover, people are becoming more health-conscious and embracing meal replacements and exercise regimens in order to keep fit and healthy. This is one of the major reasons driving the weight management market growth.
Other factors driving market expansion include rising disposable incomes and consumer spending power, as well as the emergence of gym culture and an increase in the use of dietary supplements.
The global weight loss and obesity management systems market is anticipated to expand at a 5.2% CAGR from 2022 to 2028.
“Emergence of New Technologies & Therapies Assisting Market Growth”
Various big pharmaceutical companies are developing novel anti-obesity drugs for weight loss and obesity management. Obesity is now the most investigated indication by the number of clinical trials. The obesity drugs pipeline consists of 94 trials across all stages of clinical development.
Government organizations serve numerous vital functions in a national public health crisis, including the childhood obesity epidemic. It provides leadership by responding to prevalent obesity as an urgent public health priority and coordinating the public and private sector response.
Despite government policy responses and greater individual responsibility, global obesity levels look set to keep rising. Government regulations and taxes might increase awareness of weight management and put pressure on food and beverage companies to reduce the calorific value of their products.
“Side Effects of Drugs & Other Risks Associated with Weight Loss Surgeries to Obstruct Demand for Surgical Equipment”
It has been proven that bariatric surgery is more effective in terms of cost and treatment than other pharmaceutical interventions for weight loss and obesity management. However, this proven effectiveness is typically associated with certain risks that cannot be understated. Some of the major risks associated are excessive bleeding, infections, blood clots, low blood sugar, and malnutrition.
High cost involved in the R&D of obesity drugs is a great challenge for the growth of the market. Side effects of drugs and risks associated with surgeries may hamper the growth of the global weight loss management market during the forecast period.
“Rising Initiatives for Healthy Lifestyles Driving Market Growth in North America”
North America is expected to account 43% share of the weight loss and obesity management market in 2022. Major factors boosting the market growth in the region include the rising prevalence of obesity and chronic diseases, favorable government initiatives about nutrition and healthy lifestyles, a growing number of fitness centers, and a rise in disposable income.
Growing awareness about obesity management in the population and the presence of major drug manufacturers are driving the market growth in North America.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Rapid Adoption of Weight Loss Management Services to Augment Market Growth”
Rising investments & collaborations in weight loss and obesity management business, rising disposable incomes coupled with changing lifestyles due to rapid urbanization, and commercial availability of liposuction devices are the factors driving market expansion in the U.S.
Increasing incidences of hypertension & diabetes and high adoption of weight loss management services are expected to drive the market growth in the U.S. over the coming years.
“Growing Medical Tourism Driving Market Expansion in India”
Obesity management is an evolving area of focus, which has been witnessing an upsurge in demand, due to the increasing medical tourism in India.
Rising medical tourism for weight loss and obesity management in India provides immense opportunities for the weight loss and obesity management market players to launch products that would further contribute to driving the growth of the global weight loss and obesity management market.
“Increasing Number of Bariatric Surgeries Driving Demand for Bariatric Stapling Devices”
After eating, exercise, and other medically advised weight loss programs failed, bariatric procedures/weight loss surgeries were once thought to be the last option for weight loss. Bariatric stapling devices type USD share will increase significantly in the global weight loss and obesity management market.
Many bariatric stapling devices are being used for bariatric surgeries, which help in controlling hunger by electrically stimulating the nerves that control our hunger signals. Bariatric operations have become less painful for patients as a result of recent innovations.
As a result, the medical profession is increasingly accepting these surgeries as a viable and long-lasting alternative to traditional weight-loss methods. Hence bariatric stapling devices are in more demand.
“Online Sales Most Preferred Because of Easy Availability of Products”
By distribution channel, the online sales channel USD is expected to gain the largest share over the coming years. The rate of internet penetration has risen dramatically during the last several years around the world. According to reports, over 54% of the world's population has internet connections.
As a result, the weight reduction and weight management business have seen an increase in the use of digital services. Obesity has become a major concern worldwide as meal replacements and exercise are inadequate for weight loss and obesity management.
Sometimes targeted treatments must be combined with additional pharmacologic therapy drugs. The easy availability of drugs, high-quality food, and dietary supplements are driving the demand for online sales channels.
The COVID-19 pandemic has had a severe impact on the market. Weight loss and obesity management products suffered a drop in sales during the pandemic, according to the medical device industry. Because of the growing COVID-19 infection, hospitals have postponed or rescheduled non-essential surgical and non-invasive procedures.
Demand for fitness equipment has surged as individuals have become more health-conscious. Technological platforms and solutions are being implemented to handle rising consumer demand, change consumer behavior, and improve supply chains and raw material sourcing. The market is stabilizing and appears to have the most potential for growth over the coming years.
Key weight loss and obesity management equipment manufacturers are taking a few to hold a competitive edge in the market. Companies are focusing on launching advanced surgical equipment and training equipment, which is propelling the global weight loss and obesity treatment market forward.
For instance,
Attributes | Details |
---|---|
Forecast Period | 2022 to 2028 |
Historical Data Available for | 2013 to 2021 |
Market Analysis | Value in US$ Million |
Key Regions Covered |
|
Key Countries Covered |
|
Key Market Segments Covered |
|
Key Companies Profiled |
|
Pricing | Available upon Request |
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Success Factors 3.1. Regulatory Scenario 3.2. Pipeline Assessment 3.3. Potential of Anti-Obesity Drugs In The Market 3.4. Key Market Entry Strategies 3.5. White Space Analysis 4. Global Market - Pricing Analysis 4.1. Regional Pricing Analysis By Product Type 4.2. Pricing Break-up 4.2.1. Manufacturer Level Pricing 4.2.2. Distributor Level Pricing 4.3. Global Average Pricing Analysis Benchmark 5. Global Market Demand (in Value or Size in US$ Mn) Analysis 2013-2021 and Forecast, 2022-2028 5.1. Historical Market Value (US$ Mn) Analysis, 2013-2021 5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2028 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Market Background 6.1. Macro-Economic Factors 6.1.1. Increasing Investments Towards Obesity Treatment 6.1.2. Global Increase In Healthcare Spending 6.1.3. Shift Towards A Value-Based Healthcare Model 6.2. Forecast Factors - Relevance & Impact 6.2.1. New/Approved Product Launches 6.2.2. Treatment Rate 6.2.3. Prevalence of Obesity 6.2.4. Technological Advancements 6.2.5. Acceptance of Drugs by Prescribers 6.2.6. Reimbursement Policies 6.2.7. Product Penetration Rate Across End Users 6.2.8. Adoption Rate among Patients 6.2.9. Product Penetration across Regions 6.2.10. Penetration of Product in Different Distribution Channel 6.3. Value Chain 6.4. Market Dynamics 6.4.1. Drivers 6.4.2. Restraints 6.4.3. Opportunity Analysis 7. Global Market Analysis 2013-2021 and Forecast 2022-2028, by Product Type 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2013 - 2021 7.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2022 - 2028 7.3.1. Devices 7.3.1.1. Liposuction Device 7.3.1.1.1. Laser Assisted Liposuction Devices 7.3.1.1.2. Radio Frequency Assisted Liposuction Devices 7.3.1.1.3. Ultrasound Assisted Liposuction Devices 7.3.1.2. Bariatric Stapling Devices 7.3.1.3. Gastric Band 7.3.1.4. Gastric Balloon Systems 7.3.1.5. Gastric Emptying Systems 7.3.1.6. Gastric Electrical Stimulation Systems 7.3.2. Drugs 7.3.2.1. GLP-1 receptor agonists 7.3.2.2. Lipase Inhibitors 7.3.2.3. Serotonin Receptor Agonist 7.3.2.4. Combination Drug 7.3.2.5. Others 7.4. Market Attractiveness Analysis By Product Type 8. Global Market Analysis 2013-2021 and Forecast 2022-2028, by Distribution Sales 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Distribution Sales, 2013 - 2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Sales, 2022 - 2028 8.3.1. Institutional Sales 8.3.1.1. Hospitals 8.3.1.2. Weightloss Clinics 8.3.1.3. Ambulatory Surgery Centers 8.3.2. Retail Sales 8.3.2.1. Retail Pharmacies 8.3.2.2. Drug Stores 8.3.2.3. Online Sales 8.4. Market Attractiveness Analysis By Distribution Sales 9. Global Market Analysis 2013-2021 and Forecast 2022-2028, by Region 9.1. Introduction 9.2. Historical Market Size (US$ Mn) Analysis By Region, 2013 - 2021 9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2028 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. Middle East and Africa (MEA) 9.3.5. East Asia 9.3.6. South Asia 9.3.7. Oceania 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2013-2021 and Forecast 2022-2028 10.1. Introduction 10.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021 10.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028 10.3.1. By Country 10.3.1.1. U.S. 10.3.1.2. Canada 10.3.2. By Product Type 10.3.3. By Distribution Sales 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Product Type 10.4.3. By Distribution Sales 10.5. Drivers and Restraints - Impact Analysis 11. Latin America Market Analysis 2013-2021 and Forecast 2022-2028 11.1. Introduction 11.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021 11.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Product Type 11.3.3. By Distribution Sales 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Product Type 11.4.3. By Distribution Sales 11.5. Drivers and Restraints - Impact Analysis 12. Europe Market Analysis 2013-2021 and Forecast 2022-2028 12.1. Introduction 12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021 12.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. Italy 12.3.1.3. France 12.3.1.4. U.K. 12.3.1.5. Spain 12.3.1.6. Russia 12.3.1.7. Rest of Europe 12.3.2. By Product Type 12.3.3. By Distribution Sales 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product Type 12.4.3. By Distribution Sales 12.5. Drivers and Restraints - Impact Analysis 13. South Asia Market Analysis 2013-2021 and Forecast 2022-2028 13.1. Introduction 13.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021 13.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028 13.3.1. By Country 13.3.1.1. India 13.3.1.2. Thailand 13.3.1.3. Indonesia 13.3.1.4. Malaysia 13.3.1.5. Rest of South Asia 13.3.2. By Product Type 13.3.3. By Distribution Sales 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product Type 13.4.3. By Distribution Sales 13.5. Drivers and Restraints - Impact Analysis 14. East Asia Market Analysis 2013-2021 and Forecast 2022-2028 14.1. Introduction 14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021 14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028 14.3.1. By Country 14.3.1.1. China 14.3.1.2. Japan 14.3.1.3. South Korea 14.3.2. By Product Type 14.3.3. By Distribution Sales 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product Type 14.4.3. By Distribution Sales 14.5. Drivers and Restraints - Impact Analysis 15. Oceania Market Analysis 2013-2021 and Forecast 2022-2028 15.1. Introduction 15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021 15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028 15.3.1. By Country 15.3.1.1. Australia 15.3.1.2. New Zealand 15.3.2. By Product Type 15.3.3. By Distribution Sales 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product Type 15.4.3. By Distribution Sales 15.5. Drivers and Restraints - Impact Analysis 16. Middle East and Africa Market Analysis 2013-2021 and Forecast 2022-2028 16.1. Introduction 16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2013 - 2021 16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2028 16.3.1. By Country 16.3.1.1. GCC Countries 16.3.1.2. Turkey 16.3.1.3. South Africa 16.3.1.4. Rest of Middle East and Africa 16.3.2. By Product Type 16.3.3. By Distribution Sales 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product Type 16.4.3. By Distribution Sales 16.5. Drivers and Restraints - Impact Analysis 17. Emerging Countries Market Analysis 2013-2021 and Forecast 2022-2028 17.1. Introduction 17.1.1. Market Value Proportion Analysis, By Key Countries 17.1.2. Global Vs. Country Growth Comparison 17.2. China Market Analysis 17.2.1. Introduction 17.2.2. Market Value Proportion Analysis by Market Taxonomy 17.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 17.2.3.1. By Product Type 17.2.3.2. By Distribution Sales 17.2.4. China Market - Competition Landscape 17.3. India Market Analysis 17.3.1. Introduction 17.3.2. Market Value Proportion Analysis by Market Taxonomy 17.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 17.3.3.1. By Product Type 17.3.3.2. By Distribution Sales 17.3.4. India Market - Competition Landscape 17.4. Brazil Market Analysis 17.4.1. Introduction 17.4.2. Market Value Proportion Analysis by Market Taxonomy 17.4.3. Market and Value (US$ Mn) Analysis and Forecast by Market Taxonomy 17.4.3.1. By Product Type 17.4.3.2. By Distribution Sales 17.4.4. Mexico Market - Competition Landscape 18. Market Structure Analysis 18.1. Brand Share Analysis of Top Players 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1. Novo Nordisk A/S 19.3.1.1. Overview 19.3.1.2. Product Portfolio 19.3.1.3. Profitability by Market Segments (Product/Channel/Region) 19.3.1.4. Sales Footprint 19.3.1.5. Strategy Overview 19.3.1.5.1. Marketing Strategy 19.3.1.5.2. Product Strategy 19.3.1.5.3. Channel Strategy 19.3.2. GlaxoSmithKline plc. 19.3.3. F. Hoffmann-La Roche AG 19.3.4. Allergan Plc 19.3.5. Johnson & Johnson Services, Inc 19.3.6. Medtronic plc. 19.3.7. Vivus Inc. 19.3.8. Eisai Co., Ltd. 19.3.9. ReShape Lifesciences, Inc. 19.3.10. Obalon Therapeutics 19.3.11. Aspire Bariatrics 19.3.12. Allurion Technologies Inc. 19.3.13. Nalpropion Pharmaceuticals, Inc. 19.3.14. Cheplapharm Arzneimittel GmbH 19.3.15. Beijing Noble Laser Technology Co., Ltd 20. Assumptions and Acronyms Used 21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 01: Pipeline Assessment of Drugs for Obesity (1/13) Table 02: Pipeline Assessment of Drugs for Obesity (2/13) Table 03: Pipeline Assessment of Drugs for Obesity (3/13) Table 04: Pipeline Assessment of Drugs for Obesity (4/13) Table 05: Pipeline Assessment of Drugs for Obesity (5/13) Table 06: Pipeline Assessment of Drugs for Obesity (6/13) Table 07: Pipeline Assessment of Drugs for Obesity (7/13) Table 08: Pipeline Assessment of Drugs for Obesity (8/13) Table 09: Pipeline Assessment of Drugs for Obesity (9/13) Table 10: Pipeline Assessment of Drugs for Obesity (10/13) Table 11: Pipeline Assessment of Drugs for Obesity (11/13) Table 12: Pipeline Assessment of Drugs for Obesity (12/13) Table 13: Pipeline Assessment of Drugs for Obesity (13/13) Table 14: Price (US$) Comparison of Medical Procedures for Weight Loss in Different Countries, 2022 Table 15: Global Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2) Table 16: Global Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2) Table 17: Global Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type Table 18: Global Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales Table 19: Global Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Region Table 20: North America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 21: North America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2) Table 22: North America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2) Table 23: North America Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Table 24: North America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales Table 25: Latin America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 26: Latin America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2) Table 27: Latin America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2) Table 28: Latin America Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type Table 29: Latin America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales Table 30: Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 31: Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2) Table 32: Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2) Table 33: Europe Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type Table 34: Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales Table 35: South Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 36: South Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2) Table 37: South Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2) Table 38: South Asia Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type Table 39: South Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales Table 40: East Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 41: East Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2) Table 42: East Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2) Table 43: East Asia Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type Table 44: East Asia Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales Table 45: Oceania Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 46: Oceania Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2) Table 47: Oceania Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2) Table 48: Oceania Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type Table 49: Oceania Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales Table 50: Middle East & Africa Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 51: Middle East & Africa Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2) Table 52: Middle East & Africa Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2) Table 53: Middle East & Africa Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type Table 54: Middle East & Africa Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales Table 55: China Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2) Table 56: China Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2) Table 57: China Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type Table 58: China Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales Table 59: India Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2) Table 60: India Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2) Table 61: India Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type Table 62: India Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales Table 63: Brazil Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (1/2) Table 64: Brazil Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Product Type (2/2) Table 65: Brazil Market Volume (Units) Analysis 2013-2021 and Forecast 2022-2028, By Product Type Table 66: Brazil Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Distribution Sales
Figure 01: Market size (US$ Mn) 2022E, 2022F, & 2028F Figure 02: Market Value Share by Product Type (2022E) Figure 03: Obesity Drug Development Pipeline by Phase Figure 04: Per-Capita Pharmaceutical Spending and Absolute Incidence of Obesity Figure 05: Percent of Patients Remaining on Therapy Over 1 Year Figure 06: Global Market Size and Y-o-Y, 2013 - 2021 Figure 07: Global Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 08: Global Market Absolute $ Opportunity, 2021–2028 Figure 09: Increasing Prevalence of Obesity in Adults, by Region, 1990-2014 Figure 10: Increasing number of Bariatric Surgery Numbers, 2011-2021 Figure 11: Global Market Share Analysis (%) By Product Type, 2022 & 2028 Figure 12: Global Market Y-o-Y Growth (%) By Product Type, 2022–2028 Figure 13: Global Market Attractiveness Analysis, By Product Type Figure 14: Global Market Share Analysis (%) By Distribution Sales, 2022 & 2028 Figure 15: Global Market Y-o-Y Growth (%) By Distribution Sales, 2022–2028 Figure 16: Global Market Attractiveness Analysis, By Distribution Sales Figure 17: Global Market Share Analysis (%) By Region, 2022 & 2028 Figure 18: Global Market Y-o-Y Growth (%) By Region, 2022–2028 Figure 19: Global Market Attractiveness Analysis, By Region Figure 20: North America Market Value Share, by Country (2022) Figure 21: North America Market Value Share, by Product Type (2022) Figure 22: North America Market Value Share, by Distribution Sales (2022) Figure 23: North America Market Size (US$ Mn) Analysis, 2013-2021 Figure 24: North America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028 Figure 25: North America Market Y-o-Y growth (%) Comparison, By Country, 2022-2028 Figure 26: North America Market Size (US$ Mn) Analysis, 2013-2021, by Devices Figure 27: North America Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Devices Figure 28: North America Market Size (US$ Mn) Analysis, 2013-2021, by Drugs Figure 29: North America Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Drugs Figure 30: North America Market Attractiveness Analysis, By Country Figure 31: North America Market Attractiveness Analysis, By Product Type Figure 32: North America Market Attractiveness Analysis, By Distribution Sales Figure 33: Latin America Market Value Share, by Country (2022) Figure 34: Latin America Market Value Share, by Product Type (2022) Figure 35: Latin America Market Value Share, by Distribution Sales (2022) Figure 36: Latin America Market Size (US$ Mn) Analysis, 2013-2021 Figure 37: Latin America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028 Figure 38: Latin America Market Y-o-Y growth (%) Comparison, By Country, 2022-2028 Figure 39: Latin America Market Size (US$ Mn) Analysis, 2013-2021, by Devices Figure 40: Latin America Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Devices Figure 41: Latin America Market Size (US$ Mn) Analysis, 2013-2021, by Drugs Figure 42: Latin America Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Drugs Figure 43: Latin America Market Attractiveness Analysis, By Country Figure 44: Latin America Market Attractiveness Analysis, By Product Type Figure 45: Latin America Market Attractiveness Analysis, By Distribution Sales Figure 46: Europe Market Value Share, by Country (2022) Figure 47: Europe Market Value Share, by Product Type (2022) Figure 48: Europe Market Value Share, by Distribution Sales (2022) Figure 49: Europe Market Size (US$ Mn) Analysis, 2013-2021 Figure 50: Europe Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028 Figure 51: Europe Market Y-o-Y growth (%) Comparison, By Country, 2022-2028 Figure 52: Europe Market Size (US$ Mn) Analysis, 2013-2021, by Devices Figure 53: Europe Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Devices Figure 54: Europe Market Size (US$ Mn) Analysis, 2013-2021, by Drugs Figure 55: Europe Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Drugs Figure 56: Europe Market Attractiveness Analysis, By Country Figure 57: Europe Market Attractiveness Analysis, By Product Type Figure 58: Europe Market Attractiveness Analysis, By Distribution Sales Figure 59: South Asia Market Value Share, by Country (2022) Figure 60: South Asia Market Value Share, by Product Type (2022) Figure 61: South Asia Market Value Share, by Distribution Sales (2022) Figure 62: South Asia Market Size (US$ Mn) Analysis, 2013-2021 Figure 63: South Asia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028 Figure 64: South Asia Market Y-o-Y growth (%) Comparison, By Country, 2022-2028 Figure 65: South Asia Market Size (US$ Mn) Analysis, 2013-2021, by Devices Figure 66: South Asia Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Devices Figure 67: South Asia Market Size (US$ Mn) Analysis, 2013-2021, by Drugs Figure 68: South Asia Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Drugs Figure 69: South Asia Market Attractiveness Analysis, By Country Figure 70: South Asia Market Attractiveness Analysis, By Product Type Figure 71: South Asia Market Attractiveness Analysis, By Distribution Sales Figure 72: East Asia Market Value Share, by Country (2022) Figure 73: East Asia Market Value Share, by Product Type (2022) Figure 74: East Asia Market Value Share, by Distribution Sales (2022) Figure 75: East Asia Market Size (US$ Mn) Analysis, 2013-2021 Figure 76: East Asia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028 Figure 77: East Asia Market Y-o-Y growth (%) Comparison, By Country, 2022-2028 Figure 78: East Asia Market Size (US$ Mn) Analysis, 2013-2021, by Devices Figure 79: East Asia Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Devices Figure 80: East Asia Market Size (US$ Mn) Analysis, 2013-2021, by Drugs Figure 81: East Asia Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Drugs Figure 82: East Asia Market Attractiveness Analysis, By Country Figure 83: East Asia Market Attractiveness Analysis, By Product Type Figure 84: East Asia Market Attractiveness Analysis, By Distribution Sales Figure 85: Oceania Market Value Share, by Country (2022) Figure 86: Oceania Market Value Share, by Product Type (2022) Figure 87: Oceania Market Value Share, by Distribution Sales (2022) Figure 88: Oceania Market Size (US$ Mn) Analysis, 2013-2021 Figure 89: Oceania Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028 Figure 90: Oceania Market Y-o-Y growth (%) Comparison, By Country, 2022-2028 Figure 91: Oceania Market Size (US$ Mn) Analysis, 2013-2021, by Devices Figure 92: Oceania Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Devices Figure 93: Oceania Market Size (US$ Mn) Analysis, 2013-2021, by Drugs Figure 94: Oceania Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Drugs Figure 95: Oceania Market Attractiveness Analysis, By Country Figure 96: Oceania Market Attractiveness Analysis, By Product Type Figure 97: Oceania Market Attractiveness Analysis, By Distribution Sales Figure 98: Middle East & Africa Market Value Share, by Country (2022) Figure 99: Middle East & Africa Market Value Share, by Product Type (2022) Figure 100: Middle East & Africa Market Value Share, by Distribution Sales (2022) Figure 101: Middle East & Africa Market Size (US$ Mn) Analysis, 2013-2021 Figure 102: Middle East & Africa Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2022-2028 Figure 103: Middle East & Africa Market Y-o-Y growth (%) Comparison, By Country, 2022-2028 Figure 104: Middle East & Africa Market Size (US$ Mn) Analysis, 2013-2021, by Devices Figure 105: Middle East & Africa Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Devices Figure 106: Middle East & Africa Market Size (US$ Mn) Analysis, 2013-2021, by Drugs Figure 107: Middle East & Africa Market Size (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2022-2028, by Drugs Figure 108: Middle East & Africa Market Attractiveness Analysis, By Country Figure 109: Middle East & Africa Market Attractiveness Analysis, By Product Type Figure 110: Middle East & Africa Market Attractiveness Analysis, By Distribution Sales Figure 111: Global Market Value Proportion Analysis, By Emerging Countries, 2022 Figure 112: Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2022-2028 Figure 113: China Market Value Analysis (US$ Mn), 2013-2021 Figure 114: China Market Value Forecast (US$ Mn), 2022-2028 Figure 115: India Market Value Analysis (US$ Mn), 2013-2021 Figure 116: India Market Value Forecast (US$ Mn), 2022-2028 Figure 117: Brazil Market Value Analysis (US$ Mn), 2013-2021 Figure 118: Brazil Market Value Forecast (US$ Mn), 2022-2028 Figure 119: Global Market Brand Share (%) Analysis
Recommendations
Explore Healthcare Insights
View Reports